News
CeTPD Outreach is a public engagement sub-team branching in the new Centre for Targeted Protein Degradation as part of the University’s School of Life Sciences.
News
CeTPD Outreach is a public engagement sub-team branching in the new Centre for Targeted Protein Degradation as part of the University’s School of Life Sciences.
Press release
University of Dundee spinout Amphista Therapeutics today announced the delivery of the first discovery milestone under a collaboration and licence agreement with global biopharmaceutical company Bristol Myers Squibb.
Press release
A study that could lead to the development of new treatments for people living with Parkinson’s disease has launched at the University of Dundee.
Press release
University of Dundee spinout company Tay Therapeutics has announced a licensing deal potentially worth over $50 million in upfront and milestone payments, plus royalties.
Press release
Researchers at the University of Dundee have thanked members of the public who funded the purchase of new technology that could lead to new treatments for Parkinson’s disease.
Press release
World-leading and collaborative research undertaken at the University of Dundee has been honoured at one of the Life Sciences sector’s most prestigious award ceremonies.
News
Review of the Year 20212 took place last week with the Dean, Julian Blow sharing the highlights of activity within the School from 2022.
Press release
A new University of Dundee spinout opportunity hopes to create vaccines against Strep A as well as novel vaccines for other human and animal diseases, while reducing our reliance on antibiotics.
News
After a three-year absence, the Life Sciences postgraduate society, PiCLS, organised and hosted the PiCLS Symposium for 2022.
News
Parkinson’s UK leadership team and people affected by the disease visited the University of Dundee to meet with local researchers to get an overview of the work that they do.
Press release
University of Dundee spinout Amphista Therapeutics has been designated as one of the world’s most promising biotechnology companies.
Press release
Researchers from the University of Dundee have discovered a small molecule that helps to eliminate a Parkinson’s disease-causing protein
Press release
The University of Dundee and Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents, will partner to commercialise technology developed at Dundee that enhances the understanding of undruggable diseases.
Feature
A news update about the Magnificent Microbes event featuring a weeklong programme of activities that could be done in schools, with a ‘scientist Q&A’ via Teams video at the end of the week to wrap everything up.
Press release
All roads lead west for a University of Dundee scientist who is using pedal power to fund research into Parkinson’s disease.
Press release
University of Dundee spinout Amphista Therapeutics will work with global biopharmaceutical companies as part of strategic collaborations potentially worth more than $2 billion.
News
Our green space provides an educational resource to learn both about the history of medicines, as well as the ground-breaking drug discovery work going on inside our building.
News
At the end of last month, members of the Life Sciences community took part in the annual Venture Competition.
Press release
Mutations in PINK1 are the second most frequent cause of autosomal recessive early-onset Parkinson’s disease.
News
Amphista Therapeutics, the spin out company from the lab of Professor Alessio Ciulli, was awarded the ‘Financing Deal of the Year’ award 2021 at the Scrip Awards last month. This was in recognition of their $53M Series B funding.